rs764212214
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 1P and 6B. PP2BP4_ModerateBS2
The NM_000719.7(CACNA1C):c.5456G>A(p.Arg1819Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000198 in 1,612,160 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000719.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CACNA1C | ENST00000399603.6 | c.5456G>A | p.Arg1819Gln | missense_variant | 43/47 | 5 | NM_001167623.2 | ENSP00000382512.1 | ||
CACNA1C | ENST00000399655.6 | c.5456G>A | p.Arg1819Gln | missense_variant | 43/47 | 1 | NM_000719.7 | ENSP00000382563.1 | ||
CACNA1C | ENST00000682544.1 | c.5795G>A | p.Arg1932Gln | missense_variant | 46/50 | ENSP00000507184.1 | ||||
CACNA1C | ENST00000406454.8 | c.5669G>A | p.Arg1890Gln | missense_variant | 44/48 | 5 | ENSP00000385896.3 | |||
CACNA1C | ENST00000399634.6 | c.5636G>A | p.Arg1879Gln | missense_variant | 43/47 | 5 | ENSP00000382542.2 | |||
CACNA1C | ENST00000683824.1 | c.5621G>A | p.Arg1874Gln | missense_variant | 44/48 | ENSP00000507867.1 | ||||
CACNA1C | ENST00000347598.9 | c.5600G>A | p.Arg1867Gln | missense_variant | 45/49 | 1 | ENSP00000266376.6 | |||
CACNA1C | ENST00000344100.7 | c.5579G>A | p.Arg1860Gln | missense_variant | 43/47 | 1 | ENSP00000341092.3 | |||
CACNA1C | ENST00000327702.12 | c.5561G>A | p.Arg1854Gln | missense_variant | 44/48 | 1 | ENSP00000329877.7 | |||
CACNA1C | ENST00000399617.6 | c.5561G>A | p.Arg1854Gln | missense_variant | 44/48 | 5 | ENSP00000382526.1 | |||
CACNA1C | ENST00000682462.1 | c.5546G>A | p.Arg1849Gln | missense_variant | 43/47 | ENSP00000507105.1 | ||||
CACNA1C | ENST00000683781.1 | c.5546G>A | p.Arg1849Gln | missense_variant | 43/47 | ENSP00000507434.1 | ||||
CACNA1C | ENST00000683840.1 | c.5546G>A | p.Arg1849Gln | missense_variant | 43/47 | ENSP00000507612.1 | ||||
CACNA1C | ENST00000683956.1 | c.5546G>A | p.Arg1849Gln | missense_variant | 43/47 | ENSP00000506882.1 | ||||
CACNA1C | ENST00000399638.5 | c.5540G>A | p.Arg1847Gln | missense_variant | 44/48 | 1 | ENSP00000382547.1 | |||
CACNA1C | ENST00000335762.10 | c.5531G>A | p.Arg1844Gln | missense_variant | 44/48 | 5 | ENSP00000336982.5 | |||
CACNA1C | ENST00000399606.5 | c.5516G>A | p.Arg1839Gln | missense_variant | 44/48 | 1 | ENSP00000382515.1 | |||
CACNA1C | ENST00000399621.5 | c.5513G>A | p.Arg1838Gln | missense_variant | 43/47 | 1 | ENSP00000382530.1 | |||
CACNA1C | ENST00000399637.5 | c.5513G>A | p.Arg1838Gln | missense_variant | 43/47 | 1 | ENSP00000382546.1 | |||
CACNA1C | ENST00000402845.7 | c.5513G>A | p.Arg1838Gln | missense_variant | 43/47 | 1 | ENSP00000385724.3 | |||
CACNA1C | ENST00000399629.5 | c.5507G>A | p.Arg1836Gln | missense_variant | 43/47 | 1 | ENSP00000382537.1 | |||
CACNA1C | ENST00000682336.1 | c.5498G>A | p.Arg1833Gln | missense_variant | 43/47 | ENSP00000507898.1 | ||||
CACNA1C | ENST00000399591.5 | c.5480G>A | p.Arg1827Gln | missense_variant | 42/46 | 1 | ENSP00000382500.1 | |||
CACNA1C | ENST00000399595.5 | c.5480G>A | p.Arg1827Gln | missense_variant | 42/46 | 1 | ENSP00000382504.1 | |||
CACNA1C | ENST00000399649.5 | c.5474G>A | p.Arg1825Gln | missense_variant | 42/46 | 1 | ENSP00000382557.1 | |||
CACNA1C | ENST00000399597.5 | c.5456G>A | p.Arg1819Gln | missense_variant | 43/47 | 1 | ENSP00000382506.1 | |||
CACNA1C | ENST00000399601.5 | c.5456G>A | p.Arg1819Gln | missense_variant | 43/47 | 1 | ENSP00000382510.1 | |||
CACNA1C | ENST00000399641.6 | c.5456G>A | p.Arg1819Gln | missense_variant | 43/47 | 1 | ENSP00000382549.1 | |||
CACNA1C | ENST00000399644.5 | c.5456G>A | p.Arg1819Gln | missense_variant | 43/47 | 1 | ENSP00000382552.1 | |||
CACNA1C | ENST00000682835.1 | c.5456G>A | p.Arg1819Gln | missense_variant | 43/47 | ENSP00000507282.1 | ||||
CACNA1C | ENST00000683482.1 | c.5447G>A | p.Arg1816Gln | missense_variant | 43/47 | ENSP00000507169.1 | ||||
CACNA1C | ENST00000682686.1 | c.5423G>A | p.Arg1808Gln | missense_variant | 42/46 | ENSP00000507309.1 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152080Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000203 AC: 5AN: 246452Hom.: 0 AF XY: 0.0000150 AC XY: 2AN XY: 133674
GnomAD4 exome AF: 0.0000178 AC: 26AN: 1459962Hom.: 0 Cov.: 31 AF XY: 0.0000151 AC XY: 11AN XY: 726130
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152198Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74398
ClinVar
Submissions by phenotype
Timothy syndrome;C2678478:Brugada syndrome 3 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Oct 31, 2018 | - - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Sep 06, 2024 | PP2 - |
Long QT syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 29, 2022 | This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 1819 of the CACNA1C protein (p.Arg1819Gln). This variant is present in population databases (rs764212214, gnomAD 0.007%). This variant has not been reported in the literature in individuals affected with CACNA1C-related conditions. ClinVar contains an entry for this variant (Variation ID: 456980). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt CACNA1C protein function. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Cardiovascular phenotype Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 12, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at